Medite Cancer Diagnostics, Inc. reported raising $1.19 Million in an initial SEC Form D filing, from an offering of $1.5 Million
Amount Raised
$1.19 Million
Round Type
Seed
OrlandoHealthcareWho else raised in Healthcare around the same time
Companies in the same sectors as Medite Cancer Diagnostics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Osteal Therapeutics raised $7.4M on April 7, 2018.
- RefleXion Medical raised $96M on April 2, 2018.
- Praxis Precision Medicines, Inc. raised $19M on March 26, 2018.
- Purple Biotech raised an undisclosed amount on March 26, 2018.
- Pneuma Respiratory raised $6M on March 23, 2018.
- VenoStent raised $70K on March 22, 2018.
Who to call at Medite Cancer Diagnostics, Inc., and when
A new round usually means Medite Cancer Diagnostics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Medite Cancer Diagnostics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Medite Cancer Diagnostics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Medite Cancer Diagnostics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Medite Cancer Diagnostics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Medite Cancer Diagnostics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.